TY - JOUR
T1 - A Community‐Based Program of Colorectal Screening in an Asymptomatic Population
T2 - Evaluation of Screening Tests and Compliance
AU - Bat, Leon
AU - Pines, Amos
AU - Ron, Elaine
AU - Niv, Yaron
AU - Arditi, Eliahou
AU - Shemesh, Eliahou
PY - 1986/8
Y1 - 1986/8
N2 - The incidence of colorectal cancer in Ashkenazi Jews is two to three times higher than in non‐Ashkenazis. For a community colorectal screening program 1339 asymptomatic Ashkenazis over 40 yr old were asked to participate. Of these 1012 (75%) took Hemoccult II kits [fecal occult blood tests (FOBT)], and 614 (46%) personally returned them. Screenees were interviewed regarding family and personal medical history. Fourteen persons (2.3%) had positive tests, in whom colonoscopy revealed two with cancer (Dukes' B,C) and two with a >2 cm polyp. The remaining 600 persons were invited for flexible sigmoidoscopy (FS) but only 287 (48%) appeared. The mean depth of insertion of the instrument was 50.3 cm (range 30–120), but was poorer for women. FS identified lesions in 28 (9.7%) persons: three had Dukes' A carcinomas and 25 had <2 cm adenomatous polyps. Significantly more women than men accepted FOBT, but among those completing FOBT, there was no difference by sex for use of FS. Middle‐aged persons (50–69 yr) found screening more acceptable than young or older persons. Among screenees who agreed to undergo FS, a significantly larger fraction bad a first relative with colon cancer, or a personal history of colon or female genital neoplasia, compared to those not agreeing to FS. There were no differences in screenees with relatives with noncolon cancer. Eighty‐eight couples completed FOBT and were invited for FS. The decision whether or not to participate was made for both members in 81 (92%) couples. In conclusion, effective screening programs have to take into consideration compliance patterns of the target population.
AB - The incidence of colorectal cancer in Ashkenazi Jews is two to three times higher than in non‐Ashkenazis. For a community colorectal screening program 1339 asymptomatic Ashkenazis over 40 yr old were asked to participate. Of these 1012 (75%) took Hemoccult II kits [fecal occult blood tests (FOBT)], and 614 (46%) personally returned them. Screenees were interviewed regarding family and personal medical history. Fourteen persons (2.3%) had positive tests, in whom colonoscopy revealed two with cancer (Dukes' B,C) and two with a >2 cm polyp. The remaining 600 persons were invited for flexible sigmoidoscopy (FS) but only 287 (48%) appeared. The mean depth of insertion of the instrument was 50.3 cm (range 30–120), but was poorer for women. FS identified lesions in 28 (9.7%) persons: three had Dukes' A carcinomas and 25 had <2 cm adenomatous polyps. Significantly more women than men accepted FOBT, but among those completing FOBT, there was no difference by sex for use of FS. Middle‐aged persons (50–69 yr) found screening more acceptable than young or older persons. Among screenees who agreed to undergo FS, a significantly larger fraction bad a first relative with colon cancer, or a personal history of colon or female genital neoplasia, compared to those not agreeing to FS. There were no differences in screenees with relatives with noncolon cancer. Eighty‐eight couples completed FOBT and were invited for FS. The decision whether or not to participate was made for both members in 81 (92%) couples. In conclusion, effective screening programs have to take into consideration compliance patterns of the target population.
UR - http://www.scopus.com/inward/record.url?scp=0022494418&partnerID=8YFLogxK
U2 - 10.1111/j.1572-0241.1986.tb01575.x
DO - 10.1111/j.1572-0241.1986.tb01575.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 3740023
AN - SCOPUS:0022494418
SN - 0002-9270
VL - 81
SP - 647
EP - 651
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
IS - 8
ER -